FDA approves new drug for psoriasis
On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
